The effect of naltrexone on the perception and distress in tinnitus: An open-label pilot study

International Journal of Clinical Pharmacology and Therapeutics

Volumn 51, Issue 1, 2013, Pages 5-11

  Vanneste, Sven ^a,b   Azevedo, Andréia ^c   De Ridder, Dirk ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c OTOSUL   (Brazil)

Author keywords

Distress; Naltrexone; Tinnitus

Indexed keywords

NALTREXONE;

ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; OPEN STUDY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; TINNITUS; VISUAL ANALOG SCALE;

ANALYSIS OF VARIANCE; ATTITUDE TO HEALTH; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; PILOT PROJECTS; STRESS, PSYCHOLOGICAL; TINNITUS;

EID: 84871912849     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CP201754     Document Type: Article

References (62)

1. Henry JA, Dennis KC, Schechter MA. General review of tinnitus: prevalence, mechanisms, effects, and management. J Speech Lang Hear Res. 2005; 48: 1204-1235. doi:10.1044/1092-4388(2005/084) PubMed (Pubitemid 43190588)
2. Baguley DM. Mechanisms of tinnitus. Br Med Bull. 2002; 63: 195-212. doi:10.1093/bmb/63.1.195 PubMed (Pubitemid 35175761)
3. Eggermont JJ, Roberts LE. The neuroscience of tinnitus. Trends Neurosci. 2004; 27: 676-682. doi:10.1016/j.tins.2004.08.010 PubMed (Pubitemid 39335838)
4. Heller AJ. Classification and epidemiology of tinnitus. Otolaryngol Clin North Am. 2003; 36: 239-248. doi:10.1016/S0030-6665(02)00160-3 PubMed (Pubitemid 36529941)
5. Axelsson A, Ringdahl A. Tinnitus - a study of its prevalence and characteristics. Br J Audiol. 1989; 23: 53-62. doi:10.3109/03005368909077819 PubMed (Pubitemid 19087668)
6. Jastreboff PJ. Phantom auditory perception (tinnitus): mechanisms of generation and perception. Neurosci Res. 1990; 8: 221-254. doi:10.1016/0168- 0102(90)90031-9 PubMed (Pubitemid 20309378)
7. De Ridder D, De Mulder G, Verstraeten E, Sunaert S, Moller A. Somatosensory cortex stimulation for deafferentation pain. Acta Neurochir Suppl (Wien). 2007; 97: 67-74. doi:10.1007/978-3-211-33081-4-8 PubMed
8. Møller AR. Tinnitus and pain. Prog Brain Res. 2007; 166: 47-53. doi:10.1016/S0079-6123(07)66004-X PubMed (Pubitemid 47588058)
9. Mühlnickel W, Elbert T, Taub E, Flor H. Reorganization of auditory cortex in tinnitus. Proc Natl Acad Sci USA. 1998; 95: 10340-10343. doi:10.1073/pnas.95.17.10340 PubMed (Pubitemid 28415343)
10. Salvi RJ, Wang J, Ding D. Auditory plasticity and hyperactivity following cochlear damage. Hear Res. 2000; 147: 261-274. doi:10.1016/S0378-5955(00)00136- 2 PubMed (Pubitemid 30658071)
11. Elgoyhen AB, Langguth B. Pharmacological approaches to the treatment of tinnitus. Drug Discov Today. 2010; 15: 300-305. doi:10.1016/j.drudis.2009.11.003 PubMed
12. Darlington CL, Smith PF. Drug treatments for tinnitus. Prog Brain Res. 2007; 166: 249-262. doi:10.1016/S0079-6123(07)66023-3 PubMed (Pubitemid 47588073)
13. Dobie RA. A review of randomized clinical trials in tinnitus. Laryngoscope. 1999; 109: 1202-1211. doi:10.1097/00005537-199908000-00004 PubMed (Pubitemid 29379426)
14. Patterson MB, Balough BJ. Review of pharmacological therapy for tinnitus. Int Tinnitus J. 2006; 12: 149-159. PubMed (Pubitemid 46032585)
15. Dobie RA, Sakai CS, Sullivan MD, Katon WJ, Russo J. Antidepressant treatment of tinnitus patients: report of a randomized clinical trial and clinical prediction of benefit. Am J Otol. 1993; 14: 18-23. PubMed (Pubitemid 23037487)
16. Sullivan M, Katon W, Russo J, Dobie R, Sakai C. A randomized trial of nortriptyline for severe chronic tinnitus. Effects on depression, disability, and tinnitus symptoms. Arch Intern Med. 1993; 153: 2251-2259. doi:10.1001/archinte.1993.00410190091011 PubMed (Pubitemid 23296492)
17. Zöger S, Svedlund J, Holgers KM. The effects of sertraline on severe tinnitus suffering - a randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol. 2006; 26: 32-39. doi:10.1097/01.jcp.0000195111.86650.19 PubMed (Pubitemid 43167088)
18. Mardini MK. Ear-clicking "tinnitus" responding to carbamazepine. N Engl J Med. 1987; 317: 1542. doi:10.1056/NEJM198712103172418 PubMed
19. Bauer CA, Brozoski TJ. Effect of gabapentin on the sensation and impact of tinnitus. Laryngoscope. 2006; 116: 675-681. doi:10.1097/01.MLG.0000216812. 65206.CD PubMed (Pubitemid 44318020)
20. Guitton MJ, Wang J, Puel JL. New pharmacological strategies to restore hearing and treat tinnitus. Acta Otolaryngol. 2004; 124: 411-415. doi:10.1080/00016480310000665 PubMed (Pubitemid 38797596)
21. Azevedo AA, Figueiredo RR. Treatment of tinnitus with acamprosate. Prog Brain Res. 2007; 166: 273-277. doi:10.1016/S0079-6123(07)66025-7 PubMed (Pubitemid 47595309)
22. Salembier L, De Ridder D, Van de Heyning PH. The use of flupirtine in treatment of tinnitus. Acta Otolaryngol Suppl. 2006; 126 (s556): 93-95. doi:10.1080/03655230600895242 PubMed
23. Johnson RM, Brummett R, Schleuning A. Use of alprazolam for relief of tinnitus. A double-blind study. Arch Otolaryngol Head Neck Surg. 1993; 119: 842-845. doi:10.1001/archotol.1993.01880200042006 PubMed (Pubitemid 23232291)
24. Kay NJ. Oral chemotherapy in tinnitus. Br J Audiol. 1981; 15: 123-124. doi:10.3109/03005368109081425 PubMed (Pubitemid 12161731)
25. Younger J, Mackey S. Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study. Pain Med. 2009; 10: 663-672. doi:10.1111/j.1526-4637. 2009.00613.x PubMed
26. Smith JP, Stock H, Bingaman S, Mauger D, Rogosnitzky M, Zagon IS. Low-dose naltrexone therapy improves active Crohn's disease. Am J Gastroenterol. 2007; 102: 820-828. doi:10.1111/j.1572-0241.2007.01045.x PubMed (Pubitemid 46496605)
27. Gironi M, Martinelli-Boneschi F, Sacerdote P, Solaro C, Zaffaroni M, Cavarretta R, Moiola L, Bucello S, Radaelli M, Pilato V, Rodegher M, Cursi M, Franchi S, Martinelli V, Nemni R, Comi G, Martino G. A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis. Mult Scler. 2008; 14: 1076-1083. doi:10.1177/1352458508095828 PubMed
28. Kariv R, Tiomny E, Grenshpon R, Dekel R, Waisman G, Ringel Y, Halpern Z. Low-dose naltreoxone for the treatment of irritable bowel syndrome: a pilot study. Dig Dis Sci. 2006; 51: 2128-2133. doi:10.1007/s10620-006-9289-8 PubMed
29. Zubieta JK, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM, Meyer CR, Koeppe RA, Stohler CS. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science. 2001; 293: 311-315. doi:10.1126/science. 1060952 PubMed (Pubitemid 32694749)
30. Shen KF, Crain SM. Dual opioid modulation of the action potential duration of mouse dorsal root ganglion neurons in culture. Brain Res. 1989; 491: 227-242. doi:10.1016/0006-8993(89)90059-0 PubMed (Pubitemid 19163374)
31. Fan SF, Shen KF, Crain SM. Opioids at low concentration decrease openings of K+ channels in sensory ganglion neurons. Brain Res. 1991; 558: 166-170. doi:10.1016/0006-8993(91)90737-G PubMed
32. De Ridder D, De Mulder G, Menovsky T, Sunaert S, Kovacs S. Electrical stimulation of auditory and somatosensory cortices for treatment of tinnitus and pain. Prog Brain Res. 2007; 166: 377-388. doi:10.1016/S0079-6123(07)66036-1 PubMed (Pubitemid 47588083)
33. Tonndorf J. The analogy between tinnitus and pain: a suggestion for a physiological basis of chronic tinnitus. Hear Res. 1987; 28: 271-275. doi:10.1016/0378-5955(87)90054-2 PubMed (Pubitemid 17102438)
34. Micó JA, Ardid D, Berrocoso E, Eschalier A. Antidepressants and pain. Trends Pharmacol Sci. 2006; 27: 348-354. doi:10.1016/j.tips.2006.05.004 PubMed (Pubitemid 43963184)
35. Liberzon I, Taylor SF, Phan KL, Britton JC, Fig LM, Bueller JA, Koeppe RA, Zubieta JK. Altered central micro-opioid receptor binding after psychological trauma. Biol Psychiatry. 2007; 61: 1030-1038. doi:10.1016/j. biopsych.2006.06.021 PubMed (Pubitemid 46551967)
36. De Ridder D, Elgoyhen AB, Romo R, Langguth B. Phantom percepts: tinnitus and pain as persisting aversive memory networks. Proc Natl Acad Sci USA. 2011; 108: 8075-8080. doi:10.1073/pnas.1018466108 PubMed
37. De Ridder D, Vanneste S, Congedo M. The distressed brain: a group blind source separation analysis on tinnitus. PLoS ONE. 2011; 6: e24273 doi:10.1371/journal.pone.0024273 PubMed
38. van der Loo E, Congedo M, Vanneste S, Van De Heyning P, De Ridder D. Insular lateralization in tinnitus distress. Auton Neurosci. 2011; 165: 191-194. doi:10.1016/j.autneu.2011.06.007 PubMed
39. Vanneste S, Plazier M, der Loo E, de Heyning PV, Congedo M, De Ridder D. The neural correlates of tinnitus-related distress. Neuroimage. 2010; 52: 470-480. doi:10.1016/j.neuroimage.2010.04.029 PubMed
40. Jordán J, Ceña V, Prehn JH. Mitochondrial control of neuron death and its role in neurodegenerative disorders. J Physiol Biochem. 2003; 59: 129-141. doi:10.1007/BF03179878 PubMed
41. Basta D, Tzschentke B, Ernst A. Noise-induced cell death in the mouse medial geniculate body and primary auditory cortex. Neurosci Lett. 2005; 381: 199-204. doi:10.1016/j.neulet.2005.02.034 PubMed (Pubitemid 40693169)
42. San-Emeterio EP, Hurlé MA. Modulation of brain apoptosis-related proteins by the opioid antagonist naltrexone in mice. Neurosci Lett. 2006; 403: 276-279. doi:10.1016/j.neulet.2006.04.053 PubMed (Pubitemid 44016008)
43. Dobie R. Clinical trials and drug therapy for tinnitus. In: Snow JB (ed). Tinnitus: Theory and Management. Hamilton: Decker; 2004. p. 266-277.
44. Vanneste S, Focquaert F, Van de Heyning P, De Ridder D. Different resting state brain activity and functional connectivity in patients who respond and not respond to bifrontal tDCS for tinnitus suppression. Exp Brain Res. 2011; 210: 217-227. doi:10.1007/s00221-011-2617-z PubMed
45. Cools R, D'Esposito M. Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biol Psychiatry. 2011; 69: e113-e125. doi:10.1016/j.biopsych.2011.03.028 PubMed
46. Liu B, Du L, Kong LY, Hudson PM, Wilson BC, Chang RC, Abel HH, Hong JS. Reduction by naloxone of lipopolysaccharide-induced neurotoxicity in mouse cortical neuron-glia co-cultures. Neuroscience. 2000; 97: 749-756. doi:10.1016/S0306-4522(00)00057-9 PubMed (Pubitemid 30332182)
47. Cz?onkowski A, Stein C, Herz A. Peripheral mechanisms of opioid antinociception in inflammation: involvement of cytokines. Eur J Pharmacol. 1993; 242: 229-235. doi:10.1016/0014-2999(93)90246-E PubMed
48. Greeneltch KM, Haudenschild CC, Keegan AD, Shi Y. The opioid antagonist naltrexone blocks acute endotoxic shock by inhibiting tumor necrosis factor-alpha production. Brain Behav Immun. 2004; 18: 476-484. doi:10.1016/j.bbi.2003.12.001 PubMed (Pubitemid 38950843)
49. Liu B, Du L, Hong JS. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J Pharmacol Exp Ther. 2000; 293: 607-617. PubMed (Pubitemid 30244114)
50. Tsai RY, Jang FL, Tai YH, Lin SL, Shen CH, Wong CS. Ultra-low-dose naloxone restores the antinociceptive effect of morphine and suppresses spinal neuroinflammation in PTX-treated rats. Neuropsychopharmacology. 2008; 33: 2772-2782. doi:10.1038/sj.npp.1301672 PubMed
51. Younger JW, Zautra AJ, Cummins ET. Effects of naltrexone on pain sensitivity and mood in fibromyalgia: no evidence for endogenous opioid pathophysiology. PLoS ONE. 2009; 4: e5180 doi:10.1371/journal.pone.0005180 PubMed
52. Preston KL, Bigelow GE. Differential naltrexone antagonism of hydromorphone and pentazocine effects in human volunteers. J Pharmacol Exp Ther. 1993; 264: 813-823. PubMed (Pubitemid 24283545)
53. Rubinstein M, Mogil JS, Japón M, Chan EC, Allen RG, Low MJ. Absence of opioid stress-induced analgesia in mice lacking beta-endorphin by site-directed mutagenesis. Proc Natl Acad Sci USA. 1996; 93: 3995-4000. doi:10.1073/pnas.93.9.3995 PubMed (Pubitemid 26144234)
54. Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Le Meur M, Dollé P, Tzavara E, Hanoune J, Roques BP, Kieffer BL. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature. 1996; 383: 819-823. doi:10.1038/383819a0 PubMed
55. Noreña AJ, Moffat G, Blanc JL, Pezard L, Cazals Y. Neural changes in the auditory cortex of awake guinea pigs after two tinnitus inducers: salicylate and acoustic trauma. Neuroscience. 2010; 166: 1194-1209. doi:10.1016/j.neuroscience.2009.12.063 PubMed
56. Persson AI, Naylor AS, Jonsdottir IH, Nyberg F, Eriksson PS, Thorlin T. Differential regulation of hippocampal progenitor proliferation by opioid receptor antagonists in running and non-running spontaneously hypertensive rats. Eur J Neurosci. 2004; 19: 1847-1855. doi:10.1111/j.1460-9568.2004.03268.x PubMed (Pubitemid 38482572)
57. Holmes MM, Galea LA. Defensive behavior and hippocampal cell proliferation: differential modulation by naltrexone during stress. Behav Neurosci. 2002; 116: 160-168. doi:10.1037/0735-7044.116.1.160 PubMed (Pubitemid 34094576)
58. Marinelli PW, Funk D, Juzytsch W, Li Z, Lê AD. Effects of opioid receptor blockade on the renewal of alcohol seeking induced by context: relationship to c-fos mRNA expression. Eur J Neurosci. 2007; 26: 2815-2823. doi:10.1111/j.1460-9568.2007.05898.x PubMed (Pubitemid 350115512)
59. Marinelli PW, Funk D, Juzytsch W, Lê AD. Opioid receptors in the basolateral amygdala but not dorsal hippocampus mediate context-induced alcohol seeking. Behav Brain Res. 2010; 211: 58-63. doi:10.1016/j.bbr.2010.03.008 PubMed
60. Cottrell GA, Nyakas C, Bohus B. The behavioural depression of hippocampal kindled rats is attenuated by subcutaneous and intracerebroventricular naltrexone. Prog Neuropsychopharmacol Biol Psychiatry. 1984; 8: 673-676. doi:10.1016/0278-5846(84)90035-6 PubMed (Pubitemid 15193224)
61. Landgrebe M, Langguth B, Rosengarth K, Braun S, Koch A, Kleinjung T, May A, de Ridder D, Hajak G. Structural brain changes in tinnitus: grey matter decrease in auditory and non-auditory brain areas. Neuroimage. 2009; 46: 213-218. doi:10.1016/j.neuroimage.2009.01.069 PubMed
62. De Ridder D, Fransen H, Francois O, Sunaert S, Kovacs S, Van De Heyning P. Amygdalohippocampal involvement in tinnitus and auditory memory. Acta Otolaryngol Suppl. 2006; 126 (s556): 50-53. doi:10.1080/03655230600895580 PubMed